Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM) — Market Cap & Net Worth
Market Cap & Net Worth: Tempus AI, Inc. Class A Common Stock (TEM)
Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM) has a market capitalization of $8.48 Billion ($8.48 Billion) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #2547 globally and #914 in its home market, demonstrating a -0.06% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tempus AI, Inc. Class A Common Stock's stock price $48.79 by its total outstanding shares 173729901 (173.73 Million). Review TEM liabilities breakdown to assess the company's total debt and financial obligations.
Tempus AI, Inc. Class A Common Stock Market Cap History: 2024 to 2026
Tempus AI, Inc. Class A Common Stock's market capitalization history from 2024 to 2026. Data shows growth from $5.87 Billion to $8.48 Billion (10.06% CAGR).
Index Memberships
Tempus AI, Inc. Class A Common Stock is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.35% | #50 of 976 |
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.02% | #286 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.70 Trillion | 0.50% | #35 of 263 |
Weight: Tempus AI, Inc. Class A Common Stock's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Tempus AI, Inc. Class A Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tempus AI, Inc. Class A Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
8.07x
Tempus AI, Inc. Class A Common Stock's market cap is 8.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $5.87 Billion | $693.40 Million | -$705.81 Million | 8.46x | N/A |
| 2025 | $10.26 Billion | $1.27 Billion | -$245.03 Million | 8.07x | N/A |
Competitor Companies of TEM by Market Capitalization
Companies near Tempus AI, Inc. Class A Common Stock in the global market cap rankings as of June 18, 2026.
Key companies related to Tempus AI, Inc. Class A Common Stock by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #1066 globally with a market cap of $25.15 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1911 globally with a market cap of $12.48 Billion USD ( AU$17.64 Billion AUD).
- HealthEquity Inc (NASDAQ:HQY): Ranked #2875 globally with a market cap of $7.17 Billion USD.
- Hinge Health, Inc. (NYSE:HNGE): Ranked #4493 globally with a market cap of $3.58 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1066 | Veeva Systems Inc Class A | NYSE:VEEV | $25.15 Billion | $154.85 |
| #1911 | Pro Medicus Ltd | AU:PME | $12.48 Billion | AU$168.90 |
| #2875 | HealthEquity Inc | NASDAQ:HQY | $7.17 Billion | $86.33 |
| #4493 | Hinge Health, Inc. | NYSE:HNGE | $3.58 Billion | $67.04 |
Tempus AI, Inc. Class A Common Stock Historical Marketcap From 2024 to 2026
Between 2024 and today, Tempus AI, Inc. Class A Common Stock's market cap moved from $5.87 Billion to $ 8.48 Billion, with a yearly change of 10.06%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $8.48 Billion | -17.38% |
| 2025 | $10.26 Billion | +74.91% |
| 2024 | $5.87 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Tempus AI, Inc. Class A Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.48 Billion USD |
| MoneyControl | $8.48 Billion USD |
| MarketWatch | $8.48 Billion USD |
| marketcap.company | $8.48 Billion USD |
| Reuters | $8.48 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Tempus AI, Inc. Class A Common Stock
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnosti… Read more